FCH
CL icon

Freestone Capital Holdings’s Colgate-Palmolive CL Stock Holding History

Freestone Capital Holdings’s Portfolio CL Stock Details CL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$507K Sell
5,527
-1,866
-25% -$163K 0.01% 381
2026
Q1 		$630K Sell
7,393
-235
-3% -$20.9K 0.02% 309
2025
Q4 		$603K Sell
7,628
-32,395
-81% -$2.54M 0.02% 307
2025
Q3 		$3.2M Buy
40,023
+1,581
+4% +$135K 0.1% 134
2025
Q2 		$3.49M Sell
38,442
-4,748
-11% -$433K 0.12% 123
2025
Q1 		$4.05M Buy
43,190
+1,004
+2% +$89.9K 0.15% 103
2024
Q4 		$3.84M Buy
42,186
+1,166
+3% +$111K 0.13% 109
2024
Q3 		$4.26M Sell
41,020
-845
-2% -$86.1K 0.15% 105
2024
Q2 		$4.06M Buy
41,865
+642
+2% +$59.2K 0.15% 106
2024
Q1 		$3.71M Sell
41,223
-2,364
-5% -$200K 0.14% 114
2023
Q4 		$3.47M Buy
43,587
+1,583
+4% +$119K 0.16% 111
2023
Q3 		$2.99M Buy
42,004
+5,439
+15% +$407K 0.16% 110
2023
Q2 		$2.82M Buy
36,565
+96
+0.3% +$7.43K 0.11% 123
2023
Q1 		$2.74M Sell
36,469
-945
-3% -$70.3K 0.12% 118
2022
Q4 		$2.95M Sell
37,414
-1,868
-5% -$140K 0.13% 114
2022
Q3 		$2.76M Sell
39,282
-4,881
-11% -$383K 0.12% 116
2022
Q2 		$3.54M Sell
44,163
-11,528
-21% -$901K 0.14% 104
2022
Q1 		$4.22M Buy
55,691
+1,945
+4% +$154K 0.17% 123
2021
Q4 		$4.59M Buy
53,746
+4,529
+9% +$354K 0.19% 107
2021
Q3 		$3.72M Buy
49,217
+4,127
+9% +$328K 0.19% 126
2021
Q2 		$3.67M Buy
45,090
+682
+2% +$55.8K 0.18% 131
2021
Q1 		$3.5M Buy
44,408
+3,173
+8% +$249K 0.19% 130
2020
Q4 		$3.53M Buy
41,235
+1,010
+3% +$83.5K 0.21% 118
2020
Q3 		$3.1M Buy
40,225
+7,785
+24% +$594K 0.2% 101
2020
Q2 		$2.38M Buy
32,440
+26,848
+480% +$1.91M 0.03% 145
2020
Q1 		$371K Buy
+5,592
New +$394K 0.01% 281

Other funds holding CL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Freestone Capital Holdings's CL Position: Q2 2026 in Review

Freestone Capital Holdings reduced its Colgate-Palmolive (CL) stake by 25% in Q2 2026, selling an estimated $163K and leaving 5,527 shares worth $507K. The position accounts for 0.01% of the portfolio, ranked #381.

Freestone Capital Holdings first reported a position in CL in Q1 2020 and has held it in 26 quarters since. The position peaked at $4.59M in Q4 2021. 2,020 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Freestone Capital Holdings held 5,527 shares of Colgate-Palmolive worth $507K as of Q2 2026.
  • Freestone Capital Holdings sold 1,866 Colgate-Palmolive shares in Q2 2026, an estimated $163K.
  • Colgate-Palmolive made up 0.01% of Freestone Capital Holdings's portfolio in Q2 2026, its #381 holding.
  • Freestone Capital Holdings first reported a position in Colgate-Palmolive in Q1 2020 and has held it in 26 quarters since.
  • Freestone Capital Holdings's Colgate-Palmolive position peaked at $4.59M in Q4 2021.
  • 2,020 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Freestone Capital Holdings's 13F filing for Q2 2026, filed 31 Jul 2026.